Dean Rebouche cautions that while the Supreme Court has “preserved the status quo” in abortion care for now, “it doesn’t signal that these are dead arguments that others aren’t going to try and pursue.” Read More

Nebraska voters could see conflicting ballot measures on abortion regulation this fall. Dean Rachel Rebouche says it may come down to voter outreach: “Each side has a stable group of supporters. But how are they going to reach people who have abortion ambivalence and convince them that their stance is the best option?” Read More

Louisiana is considering a bill to classify abortion pills as controlled substances, typically reserved for drugs at risk for abuse. Dean Rebouche says it’s part of an effort to paint the drugs as dangerous and stems from the decision in Dobbs.  “There’s not a threat of overdose,” she said. “There’s not a threat of addiction …. This is what Dobbs wrought.” Read More

Kean Family Dean Rachel Rebouche talked with the Philadelphia Business Journal about the law school’s comprehensive student success plan and how she’s “thinking innovatively” about what new lawyers need. Read More

Virginia governor Glenn Younkin has vetoed a package of bills that would have created shield laws for abortion providers. Dean Rebouche explains why seven other states have passed such bills and why some lawmakers have concerns. Read More

Several Justices seemed skeptical about plaintiffs’ standing in a Supreme Court case challenging the FDA’s approval of mifepristone. Dean Rebouche says a dismissal on such grounds will likely not deter future litigation with different plaintiffs. Read More

The Supreme Court will hear arguments at the end of April about whether a federal emergency care law supersedes Idaho’s near-total abortion ban. Dean Rebouche and co-authors David S. Cohen and Greer Donley have filed a brief arguing that it does and calling on the Court to overrule Dobbs. Read More

As the Supreme Court considers a case about the FDA’s regulation of mifepristone, Dean Rachel Rebouche explains how the outcome could impact not just access to abortion care but the FDA’s authority to do its job. Read More

Dean Rachel Rebouche explains what’s at stake in a case currently before the Supreme Court over the FDA’s regulation of mifepristone, one of two drugs used in medication abortion. Read More

Dean Rachel Rebouche joins frequent co-authors David S. Cohen and Greer Donley, taking a deep dive on Law Dork into abortion and reproductive rights before the Supreme Court. Read More